• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. ENGAGE POROUS TIBIAL TRAY SZ 3-LT MED; PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. ENGAGE POROUS TIBIAL TRAY SZ 3-LT MED; PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER Back to Search Results
Catalog Number 1-10012-300
Device Problem Failure to Osseointegrate (1863)
Patient Problems Failure of Implant (1924); Pain (1994); Inadequate Osseointegration (2646)
Event Date 02/03/2023
Event Type  Injury  
Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Event Description
It was reported that after unicompartmental knee arthroplasty (uka) of an engage system had been performed, the patient experienced excessive pain.This adverse event was treated with a revision surgery conducted on (b)(6) 2023.During the surgery it was noticed that the femoral component was loose with zero bone ingrowth, the tibial component had minimal bone ingrowth and pathological stress shielding around the anchor, and there was significant poly wear.The current health status of the patient is unknown.
 
Manufacturer Narrative
The associated device was returned and evaluated.The visual inspection revealed did not reveal the stated failure mode.The clinical/medical investigation concluded that, as of the date of this medical investigation, the requested clinical documentation has not been provided; therefore, there were no clinical factors found which would have contributed to the event.The definitive clinical root cause and patient outcome and/or impact beyond that which has been reported in the complaint cannot be confirmed nor concluded.A review of the production record did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history based on the historical data revealed similar previous events, however, no commonalities that would suggest a device deficiency were found.A review of the instructions for use documents for engage partial knee system revealed in the adverse effects and complications section that loosening or wear of one or more of the prosthetic components is often related to the risk factors identified in this document.Loosening can also occur as a result of an incorrect fixation or positioning of the components and pain as a result of improper positioning, loosening or wear of the components.Also, damaged fixation or implant loosening may happen as a result of bone resorption.There is not enough data available to conclude that the overall clinical benefit outweighs the potential risk profile when compared to the state of the art.The existing data identifies a potential signal that the performance is an outlier vs the state of the art with respect to the risk for revision.In addition, a historical review concluded that no previous escalated actions for this type of issue were identified.However, as a correction action a voluntary market removal will be performed for the engage cementless partial knee system due recent complaint data that indicates that the revision rate may be trending higher than corresponding similar devices in global joint replacement registries.At this time, we have no reason to suspect that the product failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include abnormal motion over time, bone degeneration, size selected, lack of ingrowth, osteolysis and/or traumatic injury.Based on this investigation, the need for corrective action may be indicated.
 
Event Description
It was reported that after a left engage unicompartmental knee arthroplasty (uka) was performed in (b)(6) 2022, the patient experienced excessive pain, even after attending therapy.This adverse event was treated with a revision surgery conducted on (b)(6) 2023.During the surgery it was noticed that the femoral component was loose with zero bone ingrowth, the tibial component had minimal bone ingrowth and pathological stress shielding around the anchor, and there was significant poly wear.The patient reported to have a great recovery.
 
Manufacturer Narrative
B5 (event description).D4 (lot number).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENGAGE POROUS TIBIAL TRAY SZ 3-LT MED
Type of Device
PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16448391
MDR Text Key310320575
Report Number1020279-2023-00422
Device Sequence Number1
Product Code HSX
UDI-Device Identifier00885556873151
UDI-Public885556873151
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190439
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 11/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1-10012-300
Device Lot Number100264-X
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberRES 92286
Patient Sequence Number1
Treatment
ENGAGE TIBIAL ANCHOR STEM SZ 3-4; ENGAGE TIBIAL INSERT SZ 3-LT MED 9MM
Patient Outcome(s) Required Intervention; Hospitalization;
-
-